CEL-SCI CORPORATION Depreciation
CEL-SCI CORPORATION (CVM) reported Depreciation of $148.94 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2015-12-11
- CEL-SCI CORPORATION depreciation for the quarter ending 2014-12-31 was $43.16K, a 3.57% increase year-over-year.
- CEL-SCI CORPORATION depreciation for the quarter ending 2014-09-30 was $45.17K, a 1.92% increase year-over-year.
- CEL-SCI CORPORATION depreciation for the quarter ending 2014-06-30 was $43.88K, a 8.46% decline year-over-year.
- CEL-SCI CORPORATION depreciation for the quarter ending 2014-03-31 was $41.72K, a 25.45% decline year-over-year.
- CEL-SCI CORPORATION depreciation for fiscal 2015 was $148.94K, a 13.63% decline from fiscal 2014.
- CEL-SCI CORPORATION depreciation for fiscal 2014 was $172.44K, a 31.86% decline from fiscal 2013.
- CEL-SCI CORPORATION depreciation for fiscal 2013 was $253.07K, a 43.22% decline from fiscal 2012.
- CEL-SCI CORPORATION depreciation for fiscal 2012 was $445.71K, a 1.59% increase from fiscal 2011.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2015-09-30 | $148.94K 10-K · filed 2015-12-11 | ||||
| 2014-12-31 | $43.16K 10-Q · filed 2015-02-06 | $88.33K derived: sum of 2 quarters · filed 2015-12-11 | $132.21K derived: sum of 3 quarters · filed 2015-12-11 | $173.93K derived: sum of 4 quarters · filed 2015-12-11 | |
| 2014-09-30 | $45.17K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $89.05K derived: sum of 2 quarters · filed 2015-12-11 | $130.77K derived: sum of 3 quarters · filed 2015-12-11 | $172.44K 10-K · filed 2015-12-11 | |
| 2014-06-30 | $43.88K 10-Q · filed 2014-08-08 | $85.59K derived: sum of 2 quarters · filed 2014-08-08 | $127.27K 10-Q · filed 2014-08-08 | $171.59K derived: sum of 4 quarters · filed 2015-12-11 | |
| 2014-03-31 | $41.72K 10-Q · filed 2014-05-12 | $83.39K 10-Q · filed 2014-05-12 | $127.71K derived: sum of 3 quarters · filed 2015-12-11 | $175.64K derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-12-31 | $41.67K 10-Q · filed 2015-02-06 | $86.00K derived: sum of 2 quarters · filed 2015-12-11 | $133.93K derived: sum of 3 quarters · filed 2015-12-11 | $189.88K derived: sum of 4 quarters · filed 2015-12-11 | |
| 2013-09-30 | $44.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $92.25K derived: sum of 2 quarters · filed 2015-12-11 | $148.21K derived: sum of 3 quarters · filed 2015-12-11 | $253.07K 10-K · filed 2015-12-11 | |
| 2013-06-30 | $47.93K 10-Q · filed 2014-08-08 | $103.89K derived: sum of 2 quarters · filed 2014-08-08 | $208.75K 10-Q · filed 2014-08-08 | $316.11K derived: sum of 4 quarters · filed 2014-12-23 | |
| 2013-03-31 | $55.96K 10-Q · filed 2014-05-12 | $160.82K 10-Q · filed 2014-05-12 | $268.18K derived: sum of 3 quarters · filed 2014-12-23 | $378.05K derived: sum of 4 quarters · filed 2014-12-23 | |
| 2012-12-31 | $104.86K 10-Q · filed 2014-02-10 | $109.55K 10-Q · filed 2013-02-08 | $212.22K derived: sum of 2 quarters · filed 2014-12-23 | $322.09K derived: sum of 3 quarters · filed 2014-12-23 | $430.62K derived: sum of 4 quarters · filed 2014-12-23 |
| 2012-09-30 | $107.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-23 | $217.23K derived: sum of 2 quarters · filed 2014-12-23 | $325.76K derived: sum of 3 quarters · filed 2014-12-23 | $445.71K 10-K · filed 2014-12-23 | |
| 2012-06-30 | $109.87K 10-Q · filed 2013-08-09 | $218.40K derived: sum of 2 quarters · filed 2013-08-09 | $338.35K 10-Q · filed 2013-08-09 | $412.40K derived: sum of 4 quarters · filed 2013-12-27 | |
| 2012-03-31 | $108.53K 10-Q · filed 2013-05-10 | $225.28K 10-Q · filed 2013-05-10 | $302.54K derived: sum of 3 quarters · filed 2013-12-27 | $426.06K derived: sum of 4 quarters · filed 2013-12-27 | |
| 2011-12-31 | $114.61K 10-Q · filed 2013-02-08 | $194.01K derived: sum of 2 quarters · filed 2013-12-27 | $317.53K derived: sum of 3 quarters · filed 2013-12-27 | $437.16K derived: sum of 4 quarters · filed 2013-12-27 | |
| 2011-09-30 | $79.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $202.91K derived: sum of 2 quarters · filed 2013-12-27 | $322.55K derived: sum of 3 quarters · filed 2013-12-27 | $438.74K 10-K · filed 2013-12-27 | |
| 2011-06-30 | $123.52K 10-Q · filed 2012-08-09 | $243.15K derived: sum of 2 quarters · filed 2012-08-09 | $359.34K 10-Q · filed 2012-08-09 | $476.80K derived: sum of 4 quarters · filed 2012-12-14 | |
| 2011-03-31 | $119.63K 10-Q · filed 2012-05-10 | $235.82K 10-Q · filed 2012-05-10 | $353.28K derived: sum of 3 quarters · filed 2012-12-14 | $466.43K derived: sum of 4 quarters · filed 2012-12-14 | |
| 2010-12-31 | $116.19K 10-Q · filed 2012-02-09 | $233.65K derived: sum of 2 quarters · filed 2012-12-14 | $346.79K derived: sum of 3 quarters · filed 2012-12-14 | ||
| 2010-09-30 | $117.45K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-14 | $230.60K derived: sum of 2 quarters · filed 2012-12-14 | $434.03K 10-K · filed 2012-12-14 | ||
| 2010-06-30 | $113.15K 10-Q · filed 2011-08-09 | $316.57K 10-Q · filed 2011-08-09 | |||
| 2009-09-30 | $329.87K 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |